Cargando…
Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4(-/-) Mice
BACKGROUND & AIMS: The endocannabinoid system is involved in the modulation of inflammatory, fibrotic, metabolic, and carcinogenesis-associated signaling pathways via cannabinoid receptor (CB)1 and CB2. We hypothesized that the pharmacologic antagonization of CB1 receptor improves cholestasis in...
Autores principales: | Helmrich, Nora, Roderfeld, Martin, Baier, Anne, Windhorst, Anita, Herebian, Diran, Mayatepek, Ertan, Dierkes, Christian, Ocker, Matthias, Glebe, Dieter, Christ, Bruno, Churin, Yuri, Irungbam, Karuna, Roeb, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873597/ https://www.ncbi.nlm.nih.gov/pubmed/34954190 http://dx.doi.org/10.1016/j.jcmgh.2021.12.013 |
Ejemplares similares
-
IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice
por: Hahn, Luisa, et al.
Publicado: (2020) -
Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2
por: Irungbam, Karuna, et al.
Publicado: (2019) -
Hepatitis B virus surface proteins accelerate cholestatic injury and tumor progression in Abcb4-knockout mice
por: Zahner, Daniel, et al.
Publicado: (2017) -
Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice
por: Irungbam, Karuna, et al.
Publicado: (2020) -
Lipid Storage and Interferon Response Determine the Phenotype of Ground Glass Hepatocytes in Mice and Humans
por: Churin, Yuri, et al.
Publicado: (2021)